astrazeneca - Search News

AstraZeneca, China

AstraZeneca shareholders say they need clarity on China investigations

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue overhanging shares: an investigation of a top executive by authorities in China, one of its key markets.

Pharmaceutical Technology on … · 15h

AstraZeneca’s shares rise as it addresses China investigation

In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company confirmed that its Chinese business is under investigation for alleged unpaid import taxes on certain cancer drugs, including Imfinzi (durvalumab) and Imjudo (tremelimumab).

AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

AstraZeneca faces potential fines in China

FiercePharma · 21h

AstraZeneca warns of potential tax fines amid China sales slowdown, illegal drug importation probe

AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities investigate the company’s former China head. | As AstraZeneca faces an ongoing investigation into alleged illegal importation of drugs in China,

The Mirror · 23h

Pharmaceutical giant AstraZeneca faces potential fines in China over import taxes

AstraZeneca appointed a new president for its China operations following the arrest of former executive Leon Wang along with other staff members by Chinese authorities

Reuters on MSN · 1d

Drugmaker AstraZeneca flags possible $4.5 million Chinese tax fine

AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its cancer drugs, the pharmaceuticals giant said on Thursday as it continues to gauge the impact of ongoing investigations in the key growth market.

1d

AstraZeneca CEO: UK must improve investment environment

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

1don MSN

AstraZeneca Expects Further Sales, Earnings Growth After Results Beat Market Views

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.

1h

AstraZeneca (AZN) Gets a Hold from Deutsche Bank

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on AstraZeneca (AZN – Research Report), with a ...

19hon MSN

Astrazeneca results, rate cut bets power FTSE 100 to record close

(Reuters) -Strong results from AstraZeneca helped London's blue-chip index notch a record close on Thursday, while a dovish ...

20h

AstraZeneca 'very disappointed' after scrapping £450m vaccine plant in Liverpool

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...

5h

AstraZeneca PLC (AZN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges

AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...

22hon MSN

Peer demands answers on AstraZeneca deal collapse

Lord Storey says he fears Merseyside was "not a high priority" on the government's growth agenda.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results